V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010039 | 280005197 | 1.69 | 108.35 | Curative (C) | 2015-09-03 | 2015-11-27 | Cisplatin | N | Y | 280025837 | CISPLATIN |
| 280010040 | 280005197 | 1.69 | 79.3 | Palliative (P) | 2015-03-07 | 2015-03-20 | PACLITAXEL | null | null | 280025837 | PACLITAXEL |
| 280010041 | 280005200 | 1.85 | 89 | Palliative (P) | 2017-07-06 | 2017-07-21 | DOXORUBICIN | 02 | N | 280025848 | DOXORUBICIN |
| 280010042 | 280008753 | 0 | 74.3 | Palliative (P) | 2015-11-18 | 2015-11-19 | PACLITAXEL | null | null | 280025861 | PACLITAXEL |
| 280010043 | 280005205 | 1.58 | 56.1 | Curative (C) | null | 2015-10-14 | CETUXIMAB + RT | 2 | Y | 280025869 | CETUXIMAB + RT |
| 280010044 | 280005208 | 1.8 | null | Adjuvant (A) | 2015-11-05 | 2015-11-29 | Cisplatin | N | Y | 280025880 | CISPLATIN |
| 280010045 | 280010449 | 0.95 | 85.2 | Disease modification (D) | 2013-09-21 | 2013-11-28 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280025889 | RMS 2005 TRIAL |
| 280010046 | 280005213 | 1.76 | 104.7 | Curative (C) | null | 2014-05-28 | Cisplatin 7 day | null | null | 280025900 | CISPLATIN |
| 280010047 | 280005217 | 1.65 | 75 | Curative (C) | 2016-10-04 | 2016-10-17 | CARBOPLATIN + RT | 02 | Y | 280025910 | CARBOPLATIN + RT |
| 280010048 | 280005221 | null | 32.2 | Palliative (P) | 2013-09-24 | 2013-10-03 | CETUXIMAB + RT | 02 | N | 280025917 | CETUXIMAB + RT |
| 280010049 | 280005222 | 0 | 58 | Curative (C) | null | 2017-12-18 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280025920 | IVA |
| 280010050 | 280010451 | 1.73 | 74.7 | Not known (9) | null | 2013-05-27 | STS Rhabdomyosarcoma RMS 2005 IVA | N | null | 280025923 | IVA |
| 280010051 | 280005224 | 1.72 | 52.2 | Neo-adjuvant (N) | 2016-04-14 | 2016-06-30 | CETUXIMAB + RT | 2 | N | 280025924 | CETUXIMAB + RT |
| 280010052 | 280011285 | 1.54 | 110 | Neo-adjuvant (N) | 2017-05-02 | 2017-05-05 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 280025932 | PACLITAXEL |
| 280010053 | 280005227 | 0 | 73 | Neo-adjuvant (N) | 2015-07-09 | 2015-07-10 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280025941 | IVA |
| 280010054 | 280008764 | 1.55 | 32.8 | Curative (C) | 2015-01-29 | 2015-02-25 | Cisplatin 7 day | 02 | Y | 280025947 | CISPLATIN |
| 280010055 | 280005230 | 1.81 | 31 | Palliative (P) | 2017-08-25 | 2017-08-26 | Ifosfamide | 02 | N | 280025954 | IFOSFAMIDE |
| 280010056 | 280005232 | 1.69 | 96 | Palliative (P) | 2015-08-15 | 2015-08-17 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 280025956 | PACLITAXEL |
| 280010057 | 280005235 | 1.9 | null | Palliative (P) | 2017-04-26 | 2017-07-23 | Cetuximab + Radiotherapy Maint | N | N | 280025968 | CETUXIMAB + RT |
| 280010058 | 280005237 | 1.69 | 104.4 | Neo-adjuvant (N) | 2017-08-20 | 2017-11-22 | DOXORUBICIN | N | N | 280025972 | DOXORUBICIN |
| 280010059 | 280008769 | 1.72 | 91 | Curative (C) | null | 2018-02-11 | Cisplatin 7 day | N | N | 280025978 | CISPLATIN |
| 280010060 | 280005240 | 1.74 | 52.2 | Curative (C) | 2016-03-20 | 2016-03-27 | Ifosfamide | N | null | 280025980 | IFOSFAMIDE |
| 280010061 | 280011287 | 1.75 | 112 | Palliative (P) | 2017-08-16 | 2017-09-12 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | null | 280025996 | PACLITAXEL |
| 280010062 | 280011901 | 1.61 | 17.7 | Palliative (P) | 2017-04-06 | 2017-04-06 | Paclitaxel 7 day | N | N | 280025997 | PACLITAXEL |
| 280010063 | 280011901 | 1.64 | 73.5 | Palliative (P) | 2013-09-27 | 2013-10-03 | Paclitaxel 7 day | N | null | 280025997 | PACLITAXEL |
| 280010064 | 280008774 | 1.51 | 60.3 | Neo-adjuvant (N) | 2017-01-09 | 2017-01-19 | Doxorubicin 75mg/m2 | 2 | null | 280026014 | DOXORUBICIN |
| 280010065 | 280005249 | 1.75 | null | Adjuvant (A) | null | 2015-10-12 | CARBOPLATIN + RT | N | null | 280026021 | CARBOPLATIN + RT |
| 280010066 | 280005251 | 1.6 | 72.8 | Palliative (P) | null | 2015-09-13 | Cetuximab + Radiotherapy Maint | N | N | 280026026 | CETUXIMAB + RT |
| 280010067 | 280005253 | 1.7 | 48.8 | Palliative (P) | 2016-03-21 | 2016-06-20 | DOXORUBICIN | N | N | 280026030 | DOXORUBICIN |
| 280010068 | 280005256 | 1.82 | 36.7 | Curative (C) | 2015-11-17 | 2016-01-06 | Cisplatin | N | Y | 280026032 | CISPLATIN |
| 280010069 | 280005261 | 1.86 | 96 | Curative (C) | 2019-05-21 | 2019-06-06 | Ifosfamide | 02 | N | 280026046 | IFOSFAMIDE |
| 280010070 | 280008780 | 1.61 | 78.5 | Neo-adjuvant (N) | 2013-12-05 | 2013-12-05 | Doxorubicin 75mg/m2 | 01 | N | 280026061 | DOXORUBICIN |
| 280010071 | 280005265 | null | 73.5 | Palliative (P) | 2017-05-28 | 2017-07-09 | Doxorubin 50mg/m2 | N | N | 280026065 | DOXORUBICIN |
| 280010072 | 280005270 | null | null | Curative (C) | 2015-03-17 | 2015-04-29 | CARBOPLATIN + RT | Y | Y | 280026069 | CARBOPLATIN + RT |
| 280010073 | 280005271 | null | 12.7 | Curative (C) | 2017-07-15 | 2017-09-18 | Cisplatin | N | N | 280026071 | CISPLATIN |
| 280010074 | 280005272 | 1.78 | null | Palliative (P) | 2017-12-09 | 2017-12-21 | Paclitaxel 7 day | 01 | N | 280026074 | PACLITAXEL |
| 280010075 | 280005275 | 0 | 14.8 | Neo-adjuvant (N) | 2017-03-16 | 2017-03-18 | IVA | 2 | N | 280026078 | IVA |
| 280010076 | 280008784 | 1.78 | 67.1 | Neo-adjuvant (N) | 2018-01-07 | 2018-01-07 | Doxorubicin 75mg/m2 | N | N | 280026080 | DOXORUBICIN |
| 280010077 | 280005277 | 1.6 | 85.4 | Palliative (P) | null | 2014-03-01 | DOXORUBICIN | N | N | 280026083 | DOXORUBICIN |
| 280010078 | 280005279 | 1.6 | 70.9 | Curative (C) | 2015-06-06 | 2015-06-27 | Cisplatin | 02 | Y | 280026097 | CISPLATIN |
| 280010079 | 280010467 | 1.66 | 84.7 | Curative (C) | 2016-04-06 | 2016-06-18 | Cetuximab + Radiotherapy Maint | 02 | N | 280026098 | CETUXIMAB + RT |
| 280010080 | 280005283 | 1.63 | 47.3 | Palliative (P) | 2014-12-10 | 2015-02-05 | CETUXIMAB + RT | N | null | 280026112 | CETUXIMAB + RT |
| 280010081 | 280005283 | 1.69 | 71 | Palliative (P) | 2016-05-09 | 2016-05-10 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 280026112 | PACLITAXEL |
| 280010082 | 280005285 | 0 | null | Palliative (P) | 2015-02-19 | 2015-04-02 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026114 | IVA |
| 280010083 | 280008789 | 1.7 | 76.9 | Palliative (P) | 2014-12-02 | 2015-01-21 | Cetuximab + Radiotherapy Maint | 2 | N | 280026118 | CETUXIMAB + RT |
| 280010084 | 280005287 | 1.82 | 87.8 | Palliative (P) | 2015-05-26 | 2015-05-29 | PACLITAXEL | 02 | N | 280026121 | PACLITAXEL |
| 280010085 | 280005288 | 0.98 | 93.8 | Not known (9) | null | 2015-02-10 | IVA | 01 | N | 280026123 | IVA |
| 280010086 | 280005293 | null | 88 | Palliative (P) | 2016-08-28 | 2016-09-01 | DOXORUBICIN | 02 | N | 280026137 | DOXORUBICIN |
| 280010088 | 280008792 | 1.76 | 90 | Palliative (P) | 2017-11-12 | 2017-11-27 | DOXORUBICIN | N | N | 280026142 | DOXORUBICIN |
| 280010089 | 280008793 | 1.74 | 92 | Palliative (P) | 2015-08-28 | 2015-08-29 | Cisplatin | 01 | N | 280026147 | CISPLATIN |